skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography

Journal Article · · Nanoscale
DOI:https://doi.org/10.1039/c6nr02618d· OSTI ID:1467020
 [1];  [1];  [2];  [3];  [4];  [2];  [1];  [1];  [1];  [5]
  1. Univ. of Pennsylvania, Philadelphia, PA (United States). Dept. of Radiology
  2. Univ. of Pennsylvania, Philadelphia, PA (United States). Dept. of Radiology and Dept. of Bioengineering
  3. Temple Univ., Philadelphia, PA (United States). Dept. of Mechanical Engineering
  4. Univ. of Pennsylvania, Philadelphia, PA (United States). Dept. of Bioengineering
  5. Univ. of Pennsylvania, Philadelphia, PA (United States). Dept. of Radiology, Dept. of Bioengineering and Dept. of Cardiology

Earlier detection of breast cancer reduces mortality from this disease. Thus, the development of better screening techniques is a topic of intense interest. Contrast-enhanced dual-energy mammography (DEM) is a novel technique that has improved sensitivity for cancer detection. However, the development of contrast agents for this technique is in its infancy. We herein report gold-silver alloy nanoparticles (GSAN) that have potent DEM contrast properties and improved biocompatibility. GSAN formulations containing a range of gold:silver ratios and capped with m-PEG were synthesized and characterized using various analytical methods. DEM and computed tomography (CT) phantom imaging showed that GSAN produced robust contrast that was comparable to silver alone. Cell viability, reactive oxygen species generation and DNA damage results revealed that the formulations with 30% or higher gold content are cytocompatible to Hep G2 and J774A.1 cells. In vivo imaging was performed in mice with and without breast tumors. The results showed that GSAN produce strong DEM and CT contrast and accumulated in tumors. Furthermore, both in vivo imaging and ex vivo analysis indicated the excretion of GSAN via both urine and feces. In summary, GSAN produce strong DEM and CT contrast, and has potential for both blood pool imaging and for breast cancer screening.

Research Organization:
Univ. of Pennsylvania, Philadelphia, PA (United States)
Sponsoring Organization:
USDOE; National Institutes of Health (NIH); Susan G. Komen Foundation; The Roentgen Fund
Contributing Organization:
Hologic, Inc., Marlborough, MA (United States)
Grant/Contract Number:
SC0012476; R00 EB012165; R03-CA171661; R01 HL131557; UL1TR000003; UL1RR024134; AC140060
OSTI ID:
1467020
Journal Information:
Nanoscale, Vol. 8, Issue 28; ISSN 2040-3364
Publisher:
Royal Society of ChemistryCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 67 works
Citation information provided by
Web of Science

References (60)

Dextran coated bismuth–iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging journal January 2014
Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis journal June 2006
Systematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applications journal October 2015
A Liposomal Nanoscale Contrast Agent for Preclinical CT in Mice journal February 2006
Nanoscale Size Effect of Magnetic Nanocrystals and Their Utilization for Cancer Diagnosis via Magnetic Resonance Imaging journal April 2005
Nanodisco Balls: Control over Surface versus Core Loading of Diagnostically Active Nanocrystals into Polymer Nanoparticles journal August 2014
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement journal November 2009
Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection journal January 2015
Toxicity of Silver Nanoparticles Increases during Storage Because of Slow Dissolution under Release of Silver Ions journal August 2010
Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography journal January 2015
Colloidal Gold Nanoparticles as a Blood-Pool Contrast Agent for X-ray Computed Tomography in Mice journal January 2007
Multiscale deformable registration for dual-energy x-ray imaging: Deformable registration for dual-energy imaging journal January 2009
Towards a nanoscale mammographic contrast agent: development of a modular pre-clinical dual optical/x-ray agent journal July 2013
The Use of Breast Imaging to Screen Women at High Risk for Cancer journal September 2010
Renal clearance of quantum dots journal September 2007
Gold nanoparticles as contrast agents in x-ray imaging and computed tomography journal January 2015
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines journal August 2011
Breast Density and Breast Cancer Risk: A Practical Review journal April 2014
Cancer Nanomedicine: From Drug Delivery to Imaging journal December 2013
Nanoalloys:  From Theory to Applications of Alloy Clusters and Nanoparticles journal March 2008
Nanoparticle contrast agents for computed tomography: a focus on micelles: NANOPARTICLE CONTRAST AGENTS FOR CT journal January 2014
X-ray CT and pneumonia inhibition properties of gold–silver nanoparticles for targeting MRSA induced pneumonia journal August 2014
Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats journal October 2015
Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size journal September 2013
Screening for Breast Cancer journal March 2005
Gold-silver alloy nanoshells: a new candidate for nanotherapeutics and diagnostics journal January 2011
Evaluation of Coronary Artery Image Quality with Knowledge-based Iterative Model Reconstruction journal June 2014
Search for novel contrast materials in dual-energy x-ray breast imaging using theoretical modeling of contrast-to-noise ratio journal July 2014
The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis journal January 2011
Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach journal April 2006
Metal-Based X-ray Contrast Media journal September 1999
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients journal October 2011
Fabrication of Au@Ag core–shell NPs as enhanced CT contrast agents with broad antibacterial properties journal May 2014
In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles journal February 2013
Synthesis, X-ray Opacity, and Biological Compatibility of Ultra-High Payload Elemental Bismuth Nanoparticle X-ray Contrast Agents journal March 2014
Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform journal November 2008
MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: Implications for clinical translation journal October 2014
Dense Breasts: A Review of Reporting Legislation and Available Supplemental Screening Options journal August 2014
Dedicated Breast CT: Initial Clinical Experience journal March 2008
MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles journal February 2003
Trimodal Gadolinium-Gold Microcapsules Containing Pancreatic Islet Cells Restore Normoglycemia in Diabetic Mice and Can Be Tracked by Using US, CT, and Positive-Contrast MR Imaging journal September 2011
Contrast Media and Nephropathy: Findings From Systematic Analysis and Food and Drug Administration Reports of Adverse Effects journal January 2006
X-Ray Computed Tomography Imaging of Breast Cancer by using Targeted Peptide-Labeled Bismuth Sulfide Nanoparticles journal October 2011
Gold Nanocrystal Labeling Allows Low-Density Lipoprotein Imaging from the Subcellular to Macroscopic Level journal October 2013
Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer journal January 2015
Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk journal April 2012
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine journal September 2010
Bilateral Contrast-enhanced Dual-Energy Digital Mammography: Feasibility and Comparison with Conventional Digital Mammography and MR Imaging in Women with Known Breast Carcinoma journal March 2013
Exploring silver as a contrast agent for contrast-enhanced dual-energy X-ray breast imaging journal September 2014
Solution-Phase Synthesis of Sub-10 nm Au−Ag Alloy Nanoparticles journal November 2002
Contrast-enhanced Dedicated Breast CT: Initial Clinical Experience journal September 2010
Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study journal June 2012
Contrast-Enhanced Digital Mammography journal May 2014
A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging journal July 2014
Distribution, Elimination, and Toxicity of Silver Nanoparticles and Silver Ions in Rats after 28-Day Oral Exposure journal July 2012
Radiation Dosimetry of the Fibrin-Binding Probe 64Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats journal May 2015
2D and 3D registration methods for dual-energy contrast-enhanced digital breast tomosynthesis conference March 2014
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles journal January 2006
The dissolution and biological effects of silver nanoparticles in biological media journal January 2014
Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine Contrast journal January 2012

Cited By (14)

Effect of Gold Nanoparticle Size on Their Properties as Contrast Agents for Computed Tomography journal October 2019
An all-in-one nanoparticle (AION) contrast agent for breast cancer screening with DEM-CT-MRI-NIRF imaging journal January 2018
Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging journal January 2018
Probing the interaction of silver nanoparticles with tau protein and neuroblastoma cell line as nervous system models journal December 2017
Gold Nanoparticles as X-Ray, CT, and Multimodal Imaging Contrast Agents: Formulation, Targeting, and Methodology journal January 2018
Role of Nanomedicine in Redox Mediated Healing at Molecular Level journal October 2019
Bimetallic Nanoparticles: Enhanced Magnetic and Optical Properties for Emerging Biological Applications journal July 2018
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency journal January 2019
Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers journal February 2018
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer journal May 2017
Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update journal November 2017
Bimetallic Nanoparticles: Enhanced Magnetic and Optical Properties for Emerging Biological Applications journal April 2018
Use of Nanoparticle Contrast Agents for Cell Tracking with Computed Tomography journal May 2017
Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells journal January 2017